Increase of permeability of synaptosomes and liposomes by the heavy chain of tetanus toxin. 1992

B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
Rudolf-Buchheim-Institut für Pharmakologie, Justus-Liebig Universität, Giessen, F.R.G.

In search of a role for the heavy chain of tetanus toxin in poisoning, its actions on natural and artificial membranes have been assessed. The heavy chain increases the permeability of synaptosomes to lactate dehydrogenase and potassium ions, and promotes the outward shift of the lipophilic cation tetraphenylphosphonium which is a particularly sensitive indicator for depolarization. Independent of the assay system the potency of the heavy chain is high, i.e. in the range of about 1 nM, whereas its efficacy is low. Its potency is decreased by the addition of the light chain and by treatment of the synaptosomes with the C-terminal fragment C of the heavy chain, but not with its N-terminal fragment beta 2. Single- or two-chain toxin itself is inactive, and so are the light chain or the two heavy chain fragments beta 2 and C. Liposomes were made from phosphatidylcholine and phosphatidylserine or gangliosides and loaded with calcein. At pH 6 the outflow of calcein is promoted in the order heavy chain greater than toxin much greater than fragment beta 2, and the action of toxin is promoted by ganglioside. At pH 5, fragment beta 2 is nearly as active as the heavy chain and more potent than the toxin. The heavy chain, but neither of the fragments, is strongly adsorbed in hydrophobic interaction chromatography and caused aggregation of polystyrene-divinylbenzene beads. Evidence for polymerization of heavy chains is lacking in zonal centrifugation. It is concluded that both domains of the heavy chain co-operate to exert the membranal events described, and that the heavy chain is partially hidden by the light chain in the complete toxin molecule.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D009861 Onium Compounds Ions with the suffix -onium, indicating cations with coordination number 4 of the type RxA+ which are analogous to QUATERNARY AMMONIUM COMPOUNDS (H4N+). Ions include phosphonium R4P+, oxonium R3O+, sulfonium R3S+, chloronium R2Cl+ Compounds, Onium
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.

Related Publications

B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
November 1992, FEBS letters,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
November 1982, Biulleten' eksperimental'noi biologii i meditsiny,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
October 2013, Avicenna journal of medical biotechnology,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
October 2015, Monoclonal antibodies in immunodiagnosis and immunotherapy,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
March 1981, Biochimica et biophysica acta,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
August 1973, Biochimica et biophysica acta,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
July 1982, Biulleten' eksperimental'noi biologii i meditsiny,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
January 1976, Naunyn-Schmiedeberg's archives of pharmacology,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
March 1987, FEBS letters,
B Högy, and M E Dauzenroth, and M Hudel, and U Weller, and E Habermann
November 1985, Nihon saikingaku zasshi. Japanese journal of bacteriology,
Copied contents to your clipboard!